Cargando…
Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis
The aim of this study was to evaluate the kynurenine pathway (KP) and amino acids profile, using mass spectrometry, in the cerebrospinal fluid (CSF) of 42 amyotrophic lateral sclerosis (ALS) patients at the diagnosis and 40 controls to detect early disorders of these pathways. Diagnostic and predict...
Autores principales: | Alarcan, Hugo, Chaumond, Romane, Emond, Patrick, Benz-De Bretagne, Isabelle, Lefèvre, Antoine, Bakkouche, Salah-eddine, Veyrat-Durebex, Charlotte, Vourc’h, Patrick, Andres, Christian, Corcia, Philippe, Blasco, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147980/ https://www.ncbi.nlm.nih.gov/pubmed/34063031 http://dx.doi.org/10.3390/biom11050691 |
Ejemplares similares
-
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients
por: Alarcan, Hugo, et al.
Publicado: (2023) -
Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020) -
Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020) -
Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2022) -
Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?
por: Alarcan, Hugo, et al.
Publicado: (2022)